Price for Cyclic Amides And Their Derivatives, And Salts Thereof (Including Cyclic Carbamates) (Excluding Ureines And Their Derivatives, And Salts Thereof) in China

China Cyclic Amides And Their Derivatives, And Salts Thereof (Including Cyclic Carbamates) (Excluding Ureines And Their Derivatives, And Salts Thereof) Export Price in September 2022

In September 2022, the cyclic amides and their derivatives, and salts thereof (including cyclic carbamates) (excluding ureines and their derivatives, and salts thereof) price stood at $11.6 per kg (FOB, China), with a decrease of -17% against the previous month. In general, the export price showed a noticeable shrinkage. The most prominent rate of growth was recorded in February 2022 an increase of 7.4% month-to-month. As a result, the export price attained the peak level of $15,498 per ton. From March 2022 to September 2022, the the average export prices failed to regain momentum.

Prices varied noticeably by the country of destination: the country with the highest price was South Korea ($16.8 per kg), while the average price for exports to Vietnam ($6,093 per ton) was amongst the lowest.

From January 2022 to September 2022, the most notable rate of growth in terms of prices was recorded for supplies to Russia (+2.2%), while the prices for the other major destinations experienced more modest paces of growth.

China Cyclic Amides And Their Derivatives, And Salts Thereof (Including Cyclic Carbamates) (Excluding Ureines And Their Derivatives, And Salts Thereof) Exports

In September 2022, exports of cyclic amides and their derivatives, and salts thereof (including cyclic carbamates) (excluding ureines and their derivatives, and salts thereof) from China soared to 18K tons, rising by 18% on the previous month. Overall, total exports indicated slight growth from January 2022 to September 2022: its volume increased at an average monthly rate of +1.9% over the last eight months. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on September 2022 figures, exports decreased by -2.8% against July 2022 indices. The most prominent rate of growth was recorded in March 2022 with an increase of 60% m-o-m. The exports peaked at 18K tons in July 2022; however, from August 2022 to September 2022, the exports remained at a lower figure.

In value terms, exports of cyclic amides and their derivatives, and salts thereof (including cyclic carbamates) (excluding ureines and their derivatives, and salts thereof) fell slightly to $208M (IndexBox estimates) in September 2022. In general, exports, however, showed a relatively flat trend pattern. The growth pace was the most rapid in May 2022 when exports increased by 46% month-to-month. The exports peaked at 255K tons in June 2022; however, from July 2022 to September 2022, the exports stood at a somewhat lower figure.

China Cyclic Amides And Their Derivatives, And Salts Thereof (Including Cyclic Carbamates) (Excluding Ureines And Their Derivatives, And Salts Thereof) Exports by Country

India (3.2K tons), the United States (3.2K tons) and Argentina (1.8K tons) were the main destinations of exports of cyclic amides and their derivatives, and salts thereof (including cyclic carbamates) (excluding ureines and their derivatives, and salts thereof) from China, with a combined 46% share of total exports.

From January 2022 to September 2022, the biggest increases were in Argentina (with a CAGR of +22.6%), while shipments for the other leaders experienced more modest paces of growth.

In value terms, the largest markets for cyclic amides and their derivatives, and salts thereof (including cyclic carbamates) (excluding ureines and their derivatives, and salts thereof) exported from China were the United States ($37M), India ($23M) and Argentina ($16M), with a combined 37% share of total exports.

Among the main countries of destination, Argentina, with a CAGR of +18.3%, saw the highest rates of growth with regard to the value of exports, over the period under review, while shipments for the other leaders experienced more modest paces of growth.